Dr James Thompson

Dr James Thompson

Dr James Thompson is a Senior Research Fellow at the Garvan Institute, a Urological Surgeon at St Vincents Clinic and St George Hospital and a Senior Lecturer at the University of New South Wales. He has an busy clinical practice and is involved in a number of clinical trials in prostate, bladder an

Biography

Dr James Thompson is a Senior Research Fellow at the Garvan Institute, a Urological Surgeon at St Vincents Clinic and St George Hospital and a Senior Lecturer at the University of New South Wales. He has an busy clinical practice and is involved in a number of clinical trials in prostate, bladder and kidney cancer. His research interest is predominantly on novel imaging techniques and biomarkers for diagnosis and risk stratification of cancer, novel robotic surgical techniques, focal ablation therapy and active surveillance for cancer.

James graduated with first class honours from medical school at University of New South Wales and undertook accredited advanced training in Urological Surgery through the Royal Australasian College of Surgeons (RACS) and Urological Society of Australia and New Zealand (USANZ). He then undertook an IMGSS fellowship in robotic cancer surgery at the largest pelvic cancer centre in the UK, University College London Hospital, as a senior robotic fellow. He was then given the honour of being the first Australasian ever appointed as a consultant robotic cancer surgeon at UCLH.

He completed his PhD in novel imaging/ biomarker techniques, robotic learning curves and active surveillance outcomes in prostate cancer in 2017, at University of New South Wales. He returned from London following being recruited as a Staff Specialist in Urology and Uro-oncology at St George Hospital in 2018 and also at St Vincents Clinic in 2018.

His current research focus continues to be novel imaging (MRI and PSMA PET) and biomarkers (genetic, epigenetic and exosomal) for the diagnosis and risk stratification of cancer, novel robotic surgical techniques in cancer surgery to improve cancer and functional outcomes, and active surveillance to reduce over-treatment of cancer. His research is focussed on prostate, bladder and to a lesser extent kidney cancer.

He has co-authored over 40 publications in peer-reviewed journals, is a regular reviewer for several prestigious urology journals, gives regular invited lectures and research presentations to local and international meetings and lectures plus supervises medical students at the University of New South Wales. He supervises PhD and Masters research fellows at the Garvan Institute and St George Medical Research Unit, as well as urological trainees and junior doctors. He chairs the Uro-oncology research collaboration meeting at St George Hospital.

In terms of collaborations, he is an executive committee member of the Australian Prostate Cancer Research Centre (APCRC) - NSW. He is an active member of the Australasian ANZUP research committee for bladder and prostate cancer. He is an active member of USANZ, the American Urological Association (AUA), European Association of Urology (EAU) and the EAU Robotic Urology Section (ERUS). 

Dr James Thompson is a Senior Research Fellow at the Garvan Institute, a Urological Surgeon at St Vincents Clinic and St George Hospital and a Senior Lecturer at the University of New South Wales. He has an busy clinical practice and is involved in a number of clinical trials in prostate, bladder and kidney cancer. His research interest is predominantly on novel imaging techniques and biomarkers for diagnosis and risk stratification of cancer, novel robotic surgical techniques, focal ablation therapy and active surveillance for cancer.

James graduated with first class honours from medical school at University of New South Wales and undertook accredited advanced training in Urological Surgery through the Royal Australasian College of Surgeons (RACS) and Urological Society of Australia and New Zealand (USANZ). He then undertook an IMGSS fellowship in robotic cancer surgery at the largest pelvic cancer centre in the UK, University College London Hospital, as a senior robotic fellow. He was then given the honour of being the first Australasian ever appointed as a consultant robotic cancer surgeon at UCLH.

He completed his PhD in novel imaging/ biomarker techniques, robotic learning curves and active surveillance outcomes in prostate cancer in 2017, at University of New South Wales. He returned from London following being recruited as a Staff Specialist in Urology and Uro-oncology at St George Hospital in 2018 and also at St Vincents Clinic in 2018.

His current research focus continues to be novel imaging (MRI and PSMA PET) and biomarkers (genetic, epigenetic and exosomal) for the diagnosis and risk stratification of cancer, novel robotic surgical techniques in cancer surgery to improve cancer and functional outcomes, and active surveillance to reduce over-treatment of cancer. His research is focussed on prostate, bladder and to a lesser extent kidney cancer.

He has co-authored over 40 publications in peer-reviewed journals, is a regular reviewer for several prestigious urology journals, gives regular invited lectures and research presentations to local and international meetings and lectures plus supervises medical students at the University of New South Wales. He supervises PhD and Masters research fellows at the Garvan Institute and St George Medical Research Unit, as well as urological trainees and junior doctors. He chairs the Uro-oncology research collaboration meeting at St George Hospital.

In terms of collaborations, he is an executive committee member of the Australian Prostate Cancer Research Centre (APCRC) - NSW. He is an active member of the Australasian ANZUP research committee for bladder and prostate cancer. He is an active member of USANZ, the American Urological Association (AUA), European Association of Urology (EAU) and the EAU Robotic Urology Section (ERUS).